Irish drugs firm Amryt Pharma eyes Nasdaq share listing

Irish-based drug development company Amryt Pharma is seeking a share listing on New York’s Nasdaq stock market.

Irish drugs firm Amryt Pharma eyes Nasdaq share listing

Irish-based drug development company Amryt Pharma is seeking a share listing on New York’s Nasdaq stock market.

The biopharmaceutical company — which has its shares listed in Dublin and London — has submitted a draft registration statement for the Nasdaq listing to the US Securities and Exchange Commission (SEC).

Amryt develops and commercialises ‘orphan’ drugs aimed at treating rare and life-threatening diseases.

Its main assets are the commercial drug Lojuxta, which treats a life-threatening disorder causing abnormally high levels of so-called ‘bad’ cholesterol, and the development drug AP101, which is seen as a possible treatment for rare skin condition epidermolysis bullosa (EB).

Last year the company bought Japanese orphan drug firm Aegerion Pharmaceuticals.

Amryt’s EB treatment is currently being studied in a Phase 3 clinical trial and recently reported that unblinded interim efficacy data supported continuation of the study with a modest increase in sample size and unblinded interim safety data allowed the inclusion of children from as young as 21 days old.

The European and US market opportunity for EB is estimated to be in excess of $1bn.

More in this section

Budget 2022 Logo

What impact will this  year's budget have on you and your business.

IE logo
Devices


UNLIMITED ACCESS TO THE IRISH EXAMINER FOR TEAMS AND ORGANISATIONS
FIND OUT MORE

The Business Hub
Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Sign up
Puzzles logo
IE-logo

Puzzles hub

Visit our brain gym where you will find simple and cryptic crosswords, sudoku puzzles and much more. Updated at midnight every day. PS ... We would love to hear your feedback on the section right HERE.

Lunchtime
News Wrap

A lunchtime summary of content highlights on the Irish Examiner website. Delivered at 1pm each day.

Sign up
Revoiced
Newsletter

Some of the best bits from irishexaminer.com direct to your inbox every Monday.

Sign up